Identification of Indicators for Preterm Birth Using Retinoid Metabolites.
Young-Ah YouSoo-Yeon HwangSoo-Min KimSeojeong ParkGa-In LeeSunwha ParkAbuZar AnsariJeongae LeeYoungjoo KwonYoung Ju KimPublished in: Metabolites (2021)
Metabolites reflect the biochemical dynamics for the maintenance of pregnancy and parturition. UPLC-Q/TOF-MS and LC-MS/MS metabolomics were performed to identify and validate the plasma metabolomic signatures of preterm birth (PTB). We recruited pregnant women between 16 and 40 weeks 5 days gestational age at Ewha Womans Mokdong Hospital for a nested case-control study. In untargeted UPLC-Q/TOF-MS, score plots of partial least-squares discriminant analysis clearly separated the PTB group from the term birth (TB, n = 10; PTB, n = 11). Fifteen metabolites were significantly different between the two groups, as indicated by a variable importance in projection >1 and p < 0.05. Metabolic pathways involving retinol, linoleic acid, D-arginine, and D-ornithine were associated with PTB. Verification by LC-MS/MS focused on retinol metabolism (TB, n = 39; PTB, n = 20). Retinol levels were significantly reduced in PTB compared to TB, while retinal palmitate, all-trans-retinal, and 13-cis-retinoic acid (13cis-RA) significantly increased (p < 0.05). Retinol-binding protein levels were also elevated in PTB. Additionally, all-trans-retinal (AUC 0.808, 95% CI: 0.683-0.933) and 13cis-RA (AUC 0.826, 95% CI: 0.723-0.930) showed improved predictions for PTB-related retinol metabolites. This study suggests that retinoid metabolism improves the accuracy of PTB predictions and plays an important role in maintaining pregnancy and inducing early parturition.
Keyphrases
- preterm birth
- gestational age
- birth weight
- low birth weight
- pregnant women
- ms ms
- optical coherence tomography
- mycobacterium tuberculosis
- binding protein
- rheumatoid arthritis
- diabetic retinopathy
- mass spectrometry
- healthcare
- body mass index
- genome wide
- nitric oxide
- simultaneous determination
- emergency department
- magnetic resonance
- ankylosing spondylitis
- case control